Dianthus Therapeutics, Inc. /DE/ Research and Development Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ research and development expense for the quarter ending 2026-06-30 was $48.69M, a 85.46% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for the quarter ending 2026-03-31 was $34.53M, a 27.87% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for the quarter ending 2025-12-31 was $59.90M, a 126.76% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for the quarter ending 2025-09-30 was $32.49M, a 27.19% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for fiscal 2025 was $145.64M, a 75.25% increase from fiscal 2024.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for fiscal 2024 was $83.11M, a 153.05% increase from fiscal 2023.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for fiscal 2023 was $32.84M, a 11.78% increase from fiscal 2022.
- Dianthus Therapeutics, Inc. /DE/ research and development expense for fiscal 2022 was $29.38M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $48.69M 10-Q · filed 2026-08-04 | $83.21M 10-Q · filed 2026-08-04 | $143.11M derived: sum of 3 quarters · filed 2026-08-04 | $175.60M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $34.53M 10-Q · filed 2026-05-05 | $94.42M derived: sum of 2 quarters · filed 2026-05-05 | $126.91M derived: sum of 3 quarters · filed 2026-05-05 | $153.16M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $59.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $92.38M derived: sum of 2 quarters · filed 2026-03-09 | $118.64M derived: sum of 3 quarters · filed 2026-08-04 | $145.64M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $32.49M 10-Q · filed 2025-11-05 | $58.74M derived: sum of 2 quarters · filed 2026-08-04 | $85.74M 10-Q · filed 2025-11-05 | $112.16M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $26.25M 10-Q · filed 2026-08-04 | $53.25M 10-Q · filed 2026-08-04 | $79.67M derived: sum of 3 quarters · filed 2026-08-04 | $105.21M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $27.00M 10-Q · filed 2026-05-05 | $53.42M derived: sum of 2 quarters · filed 2026-05-05 | $78.96M derived: sum of 3 quarters · filed 2026-05-05 | $97.03M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $26.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $51.96M derived: sum of 2 quarters · filed 2026-03-09 | $70.03M derived: sum of 3 quarters · filed 2026-03-09 | $83.11M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $25.54M 10-Q · filed 2025-11-05 | $43.61M derived: sum of 2 quarters · filed 2025-11-05 | $56.69M 10-Q · filed 2025-11-05 | $65.47M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $18.07M 10-Q · filed 2025-08-07 | $31.15M 10-Q · filed 2025-08-07 | $39.93M derived: sum of 3 quarters · filed 2025-08-07 | $47.89M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $13.08M 10-Q · filed 2025-05-12 | $21.86M derived: sum of 2 quarters · filed 2025-05-12 | $29.82M derived: sum of 3 quarters · filed 2025-05-12 | $40.07M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $16.74M derived: sum of 2 quarters · filed 2025-03-11 | $26.99M derived: sum of 3 quarters · filed 2025-03-11 | $32.84M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $7.96M 10-Q · filed 2024-11-07 | $18.21M derived: sum of 2 quarters · filed 2024-11-07 | $24.06M 10-Q · filed 2024-11-07 | $33.89M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $10.25M 10-Q · filed 2024-08-08 | $139.00K 10-Q · filed 2023-08-03 | $16.10M 10-Q · filed 2024-08-08 | $8.13M 10-Q · filed 2023-08-03 | $25.93M derived: sum of 3 quarters · filed 2024-08-08 | $33.15M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $5.85M 10-Q · filed 2024-05-09 | $8.00M 10-Q · filed 2023-05-15 | $15.68M derived: sum of 2 quarters · filed 2024-05-09 | $22.90M derived: sum of 3 quarters · filed 2024-05-09 | $34.50M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $9.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $17.05M derived: sum of 2 quarters · filed 2024-03-21 | $28.65M derived: sum of 3 quarters · filed 2024-03-21 | $29.38M 10-K · filed 2024-03-21 | $55.14M 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $7.22M 10-Q · filed 2023-11-09 | $11.20M 10-Q · filed 2022-11-03 | $18.82M derived: sum of 2 quarters · filed 2023-11-09 | $19.55M 10-Q · filed 2023-11-09 | $39.35M 10-Q · filed 2022-11-03 | $14.32M derived: sum of 4 quarters · filed 2023-12-21 | ||
| 2022-06-30 | $11.60M 10-Q · filed 2023-08-03 | $28.15M 10-Q · filed 2023-08-03 | $7.10M derived: sum of 3 quarters · filed 2023-12-21 | $17.90M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-03-31 | $16.55M 10-Q · filed 2023-05-15 | -$4.50M derived: sum of 2 quarters · filed 2023-12-21 | $6.30M derived: sum of 3 quarters · filed 2023-12-21 | $17.43M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2021-12-31 | -$21.05M derived: 8-K 12 month − 10-Q 9 month · filed 2023-12-21 | -$10.25M derived: sum of 2 quarters · filed 2023-12-21 | $878.00K derived: sum of 3 quarters · filed 2023-12-21 | $12.61M 8-K · filed 2023-12-21 | $46.77M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $10.79M 10-Q · filed 2022-11-03 | $21.92M derived: sum of 2 quarters · filed 2022-11-03 | $33.65M 10-Q · filed 2022-11-03 | $45.91M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $11.13M 10-Q · filed 2022-08-04 | $22.86M 10-Q · filed 2022-08-04 | $35.11M derived: sum of 3 quarters · filed 2022-08-04 | $46.90M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $11.73M 10-Q · filed 2022-05-16 | $23.98M derived: sum of 2 quarters · filed 2022-05-16 | $35.77M derived: sum of 3 quarters · filed 2022-05-16 | $48.38M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $12.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $24.04M derived: sum of 2 quarters · filed 2022-03-08 | $36.65M derived: sum of 3 quarters · filed 2022-03-08 | $50.62M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $11.79M 10-Q · filed 2021-11-04 | $24.40M derived: sum of 2 quarters · filed 2021-11-04 | $38.36M 10-Q · filed 2021-11-04 | $57.07M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $12.61M 10-Q · filed 2021-08-05 | $26.57M 10-Q · filed 2021-08-05 | $45.29M derived: sum of 3 quarters · filed 2021-08-05 | $61.81M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $13.96M 10-Q · filed 2021-05-06 | $32.68M derived: sum of 2 quarters · filed 2021-05-06 | $49.20M derived: sum of 3 quarters · filed 2021-05-06 | $62.63M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $18.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $35.24M derived: sum of 2 quarters · filed 2021-03-03 | $48.67M derived: sum of 3 quarters · filed 2021-03-03 | $59.21M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | $16.52M 10-Q · filed 2020-11-05 | $29.96M derived: sum of 2 quarters · filed 2020-11-05 | $40.49M 10-Q · filed 2020-11-05 | $52.88M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $13.43M 10-Q · filed 2020-08-06 | $23.97M 10-Q · filed 2020-08-06 | $36.36M derived: sum of 3 quarters · filed 2020-08-06 | $47.78M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $10.54M 10-Q · filed 2020-05-07 | $22.93M derived: sum of 2 quarters · filed 2020-05-07 | $34.34M derived: sum of 3 quarters · filed 2020-05-07 | $44.03M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $12.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $23.81M derived: sum of 2 quarters · filed 2020-03-03 | $33.49M derived: sum of 3 quarters · filed 2020-03-03 | $41.34M 10-K · filed 2020-03-03 | ||||
| 2018-09-30 | $11.42M 10-Q · filed 2019-11-13 | $21.10M derived: sum of 2 quarters · filed 2019-11-13 | $28.95M 10-Q · filed 2019-11-13 | $34.50M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | $9.68M 10-Q · filed 2019-08-08 | $17.53M 10-Q · filed 2019-08-08 | $23.08M derived: sum of 3 quarters · filed 2020-03-03 | $28.29M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | $7.85M 10-Q · filed 2019-05-09 | $13.40M derived: sum of 2 quarters · filed 2020-03-03 | $18.61M derived: sum of 3 quarters · filed 2020-03-03 | $32.43M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2017-12-31 | $5.55M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $10.76M derived: sum of 2 quarters · filed 2020-03-03 | $24.58M derived: sum of 3 quarters · filed 2020-03-03 | $27.90M 10-K · filed 2020-03-03 | ||||
| 2017-09-30 | $5.21M 10-Q · filed 2018-11-08 | $19.03M derived: sum of 2 quarters · filed 2018-11-08 | $22.35M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | $13.82M 10-Q · filed 2018-08-09 | $17.14M 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | $5.78M 10-K · filed 2019-03-19 |